Lixte Biotechnology Inc. (LIXTW)
0.03
0.01 (42.18%)
At close: Apr 21, 2025, 2:16 PM
42.18% (1D)
| Bid | 0.03 |
| Market Cap | 80.54K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.03 |
| Volume | 14,710 |
| Avg. Volume (20D) | 1,529 |
| Open | 0.03 |
| Previous Close | 0.02 |
| Day's Range | 0.02 - 0.03 |
| 52-Week Range | 0.02 - 0.09 |
| Beta | 0.32 |
About LIXTW
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It devel...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 27, 2020
Employees 2
Stock Exchange NASDAQ
Ticker Symbol LIXTW
Website https://lixte.com